SEI Investments’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

SEI Investments’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,166	Closed	-$223K	–	2904
2016 Q1	$223K	Sell	4,166 -5,925	-59%	-$437K	﹤0.01%	1498
2015 Q4	$1.14M	Sell	10,091 -15,305	-60%	-$1.69M	0.01%	1175
2015 Q3	$2.99M	Buy	+25,396	New	+$3.32M	0.03%	632

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

SEI Investments's ANAC Position: Q2 2016 in Review

SEI Investments sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 4,166 shares — an estimated $223K sold.

SEI Investments first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $2.99M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

SEI Investments reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
SEI Investments sold 4,166 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $223K.
SEI Investments first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
SEI Investments's ANACOR PHARMACEUTICALS INC COM position peaked at $2.99M in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on SEI Investments's 13F filing for Q2 2016, filed 11 Aug 2016.